Jon Corkey (Amissa Health)
Overview
Jon Corkey is the founder and CEO of Amissa Health, a digital health company rooted in Charlotte, North Carolina, and dedicated to improving health outcomes for aging populations. The startup's innovations primarily focus on the utilization of wearable technology, such as smartwatches, to collect and analyze health data for dementia research. Corkey's vision is to advance healthcare diagnostics and intervention through technology-driven methods, specifically targeting Alzheimer's disease and related cognitive impairments.
Recent Developments
In the past few years, Jon Corkey has led Amissa Health through significant advancements and partnerships, reflecting his commitment to integrating digital solutions into healthcare.
- December 2024: A study co-authored by Corkey, published in "The Journals of Gerontology," demonstrated the feasibility of using Apple Watches to monitor health behaviors in individuals with cognitive impairments. This highlighted the innovative use of wearables in identifying digital biomarkers for Alzheimer's disease (PMID: 39478338).
- November 2024: Under Corkey's stewardship, Amissa Health secured a $3 million funding round to enhance its wearable technology platform aimed at Alzheimer's research, marking a substantial expansion of their R&D capabilities (BizJournals).
- August 2023: Corkey announced the publication of a detailed proposal on scaling digital biomarker discovery via cloud computing and wearable devices, which was featured in the "Alzheimer's and Dementia" journal. This work underscores his focus on leveraging technology for public health improvements (PubMed).
- March 2023: Amissa Health, in collaboration with Massachusetts General Hospital, reported promising results from a study utilizing their smartwatch app to collect patient-generated health data, showcasing increased adherence rates among older adults (LinkedIn).
- January 2023: Corkey was featured in "Second Service Foundation's" Entrepreneur Spotlight, emphasizing his journey and innovative contributions to the health tech sector (Second Service Foundation).
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Jon A. Corkey |
| Born | Not specified |
| Nationality | American |
| Occupation | Founder and CEO of Amissa Health |
| Known For | Innovations in digital health and dementia research |
| Education | University of Colorado Boulder |
Early Life and Education
Jon Corkey's early life is not extensively documented online. However, he pursued higher education at the University of Colorado Boulder, which laid the foundation for his career in digital health innovation. His academic experiences likely provided him with a robust understanding of technological applications in healthcare, nurturing his entrepreneurial spirit. Details about his formative years suggest a blend of science-driven inquiry and a keen interest in leveraging technology for societal benefits.
Career and Notable Achievements
Corkey established Amissa Health with a vision to transform healthcare for aging populations through technology.
- 2019-Present: CEO of Amissa Health, a pioneering enterprise in digital health focused on utilizing wearable technology to create data-driven health solutions.
- 2023: Published work on scaling digital biomarker discovery, emphasizing the potential of cloud technology in healthcare (PubMed).
- 2021: Received the National Science Foundation Innovation Corps Teams Award, recognizing his and his company’s contribution towards advancing health technology (LinkedIn).
- 2019: Awarded the NC IDEA Micro Grant, which supported the growth of Amissa Health at a pivotal stage.
Current Work and Impact
Jon Corkey, as the CEO of Amissa Health, continues to innovate in the realm of digital health technologies. His work largely focuses on improving the ease and effectiveness of dementia care and diagnostics through the integration of wearable technology. By harnessing AI and machine learning, Corkey aims to empower healthcare providers with tools for better patient outcomes in aging populations. His leadership in developing accessible technology for continuous health monitoring represents a significant contribution to the field.
Conclusion
Jon Corkey has made notable strides in the health tech industry, specifically in advancing methods to improve diagnostics and interventions for neurodegenerative diseases. His entrepreneurial efforts with Amissa Health showcase his dedication to leveraging technology to meet the complex needs of aging populations. Through innovative use of wearable devices and digital biomarkers, Corkey’s work not only promises to impact current healthcare practices but also sets a foundation for future advancements in health monitoring and intervention strategies.